NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
22/11/2022
Voltar para busca
Dado oficial do USPTO
DAIM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
DAIM
ST13
US500000090898772Classe
5, 10, 35, 44
Pedido
90898772
Registro
6904558
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
20
Atualização mais recente
22/11/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 35, 44
Data de depósito
24/08/2021
Data de registro
22/11/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/11/2022
Última transação
22/11/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
London, GB
Examinador
CHUNG, ABBIE
Unidade examinadora
T70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Daim Pharma Ltd
Representantes
Joseph L. Morales THE MORALES LAW FIRM
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 35Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Vaccines; Chemical preparations for the diagnosis of diabetes; Pharmaceutical preparations for the prevention of diabetes; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the prevention of diseases of the immune system; Pharmaceutical preparations for the prevention of disorders of the immune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations for the treatment of autoimmune disorders; Pharmaceutical preparations for the prevention of autoimmune disorders; Pharmaceutical preparations for regulating the immune system; all of the aforesaid goods being for the diagnosistreatmentmanagement or prevention of Type 1 diabetes
Classe 10
Medical test kits for diabetes monitoring for home use; Testing instruments for medical diagnostic purposesmonitoring glucose level; Blood glucose testing apparatus; Apparatus for carrying-out diagnostic tests for medical purposesfor diabetes testing; Diagnosticexaminationmonitoring equipmentblood glucose monitor; Medical apparatus for testing the level of glucose in the blood; Medical apparatus and instruments for monitoring glucose levels; Medical diagnostic instruments for measuring glucose levels in blood; Medical testing instruments for recording blood glucose levels; all of the aforesaid goods being for use in the diagnosistreatmentmanagement or prevention of Type 1 diabetes
Classe 35
Advertising services relating to pharmaceuticals for the treatment of diabetes; Advertising services relating to pharmaceuticals; Advertisingmarketing and promotional services; Advertising; Advertising services to promote public awareness of medical conditions; Advertising services related to immune disorders; Advertising services related to autoimmune diseases; all of the aforesaid services being provided in connection with the diagnosistreatmentmanagement or prevention of Type 1 diabetes
Classe 44
Diabetes screening services; Medical services in the field of diabetes; Providing information via the Internet in the field of diabetes; Medical screening; Health screening services in the field of diabetes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical services for the diagnosis of conditions of the human body; Medical services; Medical diagnostic testing services; Medical services for the treatment of conditions of the human body; Medical testing services relating to the diagnosis and treatment of disease; Performing diagnosis of diseases; Medical information services provided via the Internet; Providing medical information; Medical analysis services for autoimmune disease diagnosis and prognosis; all of the aforesaid services relating to the diagnosistreatmentmanagement or prevention of Type 1 diabetes
Publicações
Histórico de despachos e eventos da marca no USPTO.
20 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
22/11/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/09/2022
PUBO
PUBLISHED FOR OPPOSITION
06/09/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/08/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
01/08/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/08/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
01/08/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/07/2022
ALIE
ASSIGNED TO LIE
19/07/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/06/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/06/2022
GNRT
NON-FINAL ACTION E-MAILED
07/06/2022
CNRT
NON-FINAL ACTION WRITTEN
07/06/2022
DOCK
ASSIGNED TO EXAMINER
26/05/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/10/2021
NWAP
NEW APPLICATION ENTERED
27/08/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DAIM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.